{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-118127","form_type":"8-K","ticker":"LABT","cik":"0002079272","company_name":"Lakewood-Amedex Biotherapeutics Inc.","filed_at":"2026-11-10T22:20:52+00:00","discovered_at":"2026-11-10T22:22:00.306745+00:00","generated_at":"2026-11-10T22:22:05.149524+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Lakewood-Amedex redeems all 127,097 Series C preferred shares for $1.27M cash","bullets":["Redeemed 127,097 Series C Convertible Preferred shares at $10.00 face value, aggregate $1,270,970 paid in cash from cash on hand.","Redemption agreement dated Nov 2, 2026 with Shakawe Capital LLC, holder of all Series C preferred; closing occurred Nov 4, 2026.","Following redemption, no preferred stock and no outstanding indebtedness for borrowed money remain; redeemed shares returned to treasury.","Company says the move eliminates potential dilution from Series C conversion and removes financing restrictions tied to the instrument.","CEO Kelvin Cooper said the redemption simplifies the capital structure and gives greater financial flexibility for development programs."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-118127","json":"https://secwatch.observer/filing/0001213900-26-118127.json","markdown":"https://secwatch.observer/filing/0001213900-26-118127.md","text":"https://secwatch.observer/filing/0001213900-26-118127.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2079272/000121390026118127/0001213900-26-118127-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2079272/000121390026118127/ea0311576-8k_lakewood.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-10T22:22:05.149524+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}